subject: CHEBI:135918

subject_name: Tucidinostat

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:135918

object_name: lymphoproliferative syndrome

tested_intervention: yes


subject: CHEBI:135918

object_name: lymphoid system disorder


subject: CHEBI:135918

object_name: Lymphadenopathy


subject: CHEBI:135918

object_name: immunoproliferative disorder


subject: CHEBI:135918

object_name: immune system disorder


subject: CHEBI:135918

object_name: Neoplasm by histology


subject: CHEBI:135918

object_name: neoplasm


subject: CHEBI:3374

subject_name: Capsaicin

object_name: pulmonary hypertension


subject: CHEBI:3374

object_name: Pulmonary Hypertension, CTCAE


subject: GTOPDB:12347

subject_name: penpulimab

object_name: head and neck squamous cell carcinoma

tested_intervention: unsure


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: CHEBI:73812

subject_name: Arg-Asp

object_name: plasma cell myeloma


subject: CHEBI:90926

subject_name: Tenofovir alafenamide

object_name: Maternal-Fetal Infection Transmission


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: Left ventricular hypertrophy


subject: PUBCHEM.COMPOUND:54214995

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: CHEBI:84040

object_name: hepatitis A


subject: CHEBI:84040

object_name: hepatitis


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: UMLS:C0138395

subject_name: Primrose oil

object_name: Blood Clot


subject: UMLS:C0138395

object_name: thrombosis


subject: UMLS:C0138395

object_name: Thrombosis of blood vessel


subject: UMLS:C0138395

object_name: type 2 diabetes mellitus


subject: UNII:3Q9L08K71N

subject_name: Evening primrose oil


subject: UNII:3Q9L08K71N


subject: UNII:3Q9L08K71N


subject: UNII:3Q9L08K71N


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Multiple polyps of nasal cavity and/or nasal sinus


subject: UMLS:C3485429

subject_name: Probiotic Formula

object_name: occupational asthma


subject: CHEBI:85990

subject_name: Panobinostat

object_name: liver cancer


subject: CHEBI:85990

object_name: liver neoplasm


subject: CHEBI:85990

object_name: Adult Liver Carcinoma


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: pervasive developmental disorder


subject: CHEBI:75832

object_name: autism


subject: CHEBI:75832

object_name: autism spectrum disorder


subject: CHEBI:75832

object_name: insomnia


subject: CHEBI:75832

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:75832

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: smoldering plasma cell myeloma


subject: MESH:D022281

subject_name: Shigella Vaccines

object_name: shigellosis


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: essential thrombocythemia


subject: CHEBI:44423

object_name: myelofibrosis


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: scrotal disorder


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Alzheimer disease


subject: UMLS:C1099192


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Mechanical Allodynia


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Nonulcer dyspepsia


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: pelvic pain on the left


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain occurs with urination


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain occurs with bowel movement


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain decreasing in severity


subject: PUBCHEM.COMPOUND:521372

object_name: Pelvic pain female


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain increasing in severity


subject: PUBCHEM.COMPOUND:521372

object_name: male pelvic pain


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain to the rear


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain on the right


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain decreasing in frequency


subject: PUBCHEM.COMPOUND:521372

object_name: Pelvic pain


subject: PUBCHEM.COMPOUND:521372

object_name: Pelvic Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain causes awakening at night


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain increasing in frequency


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain occurs with intercourse


subject: PUBCHEM.COMPOUND:521372

object_name: pelvic pain in front


subject: CHEBI:39585

subject_name: Carbidopa

object_name: endometriosis


subject: CHEBI:39585

object_name: pelvic pain on the left


subject: CHEBI:39585

object_name: pelvic pain occurs with urination


subject: CHEBI:39585

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:39585

object_name: pelvic pain decreasing in severity


subject: CHEBI:39585

object_name: Pelvic pain female


subject: CHEBI:39585

object_name: pelvic pain increasing in severity


subject: CHEBI:39585

object_name: male pelvic pain


subject: CHEBI:39585

object_name: pelvic pain to the rear


subject: CHEBI:39585

object_name: pelvic pain on the right


subject: CHEBI:39585

object_name: pelvic pain decreasing in frequency


subject: CHEBI:39585

object_name: Pelvic pain


subject: CHEBI:39585

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:39585

object_name: pelvic pain causes awakening at night


subject: CHEBI:39585

object_name: pelvic pain increasing in frequency


subject: CHEBI:39585

object_name: pelvic pain occurs with intercourse


subject: CHEBI:39585

object_name: pelvic pain in front


subject: UMLS:C2828366

subject_name: Extract (substance)

object_name: endometriosis


subject: UMLS:C2828366

object_name: red-green color blindness


subject: UMLS:C2828366

object_name: Deuteranomaly


subject: UMLS:C2828366

object_name: pelvic pain on the left


subject: UMLS:C2828366

object_name: pelvic pain occurs with urination


subject: UMLS:C2828366

object_name: pelvic pain occurs with bowel movement


subject: UMLS:C2828366

object_name: pelvic pain decreasing in severity


subject: UMLS:C2828366

object_name: Pelvic pain female


subject: UMLS:C2828366

object_name: pelvic pain increasing in severity


subject: UMLS:C2828366

object_name: male pelvic pain


subject: UMLS:C2828366

object_name: pelvic pain to the rear


subject: UMLS:C2828366

object_name: pelvic pain on the right


subject: UMLS:C2828366

object_name: pelvic pain decreasing in frequency


subject: UMLS:C2828366

object_name: Pelvic pain


subject: UMLS:C2828366

object_name: Pelvic Pain, CTCAE 5.0


subject: UMLS:C2828366

object_name: pelvic pain causes awakening at night


subject: UMLS:C2828366

object_name: pelvic pain increasing in frequency


subject: UMLS:C2828366

object_name: pelvic pain occurs with intercourse


subject: UMLS:C2828366

object_name: pelvic pain in front


subject: CHEBI:15365

subject_name: Aspirin

object_name: Pre-Gestational Diabetes


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Sicca Syndrome


subject: CHEBI:94661

subject_name: Amonafide

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:94661

object_name: acute myeloid leukemia


subject: CHEBI:63190

subject_name: (+)-beta-caryophyllene

object_name: chronic pain (diagnosis)


subject: CHEBI:63190

object_name: Chronic pain


subject: CHEBI:63190

object_name: Low back pain


subject: CHEBI:5993

subject_name: Caryophyllene


subject: CHEBI:5993


subject: CHEBI:5993


subject: PUBCHEM.COMPOUND:26318


subject: PUBCHEM.COMPOUND:26318


subject: PUBCHEM.COMPOUND:26318


subject: CHEBI:63191

subject_name: beta-caryophyllene


subject: CHEBI:63191


subject: CHEBI:63191


subject: UMLS:C0525503

subject_name: BETA-CARYOPHYLLENE


subject: UMLS:C0525503


subject: UMLS:C0525503


subject: CHEBI:114785

subject_name: Erlotinib

object_name: lip and oral cavity carcinoma


subject: CHEBI:114785

object_name: oral cavity cancer


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Aspirin-induced asthma


subject: UMLS:C0085733

subject_name: Absolute Alcohol

object_name: Malignant neoplasm of abdomen


subject: UMLS:C0085733

object_name: cancer pain


subject: UMLS:C0085733

object_name: pancreatic neoplasm


subject: UMLS:C0085733

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0085733

object_name: malignant pancreatic neoplasm


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: UMLS:C2744646

object_name: ovarian carcinoma


subject: UMLS:C2346822

subject_name: conatumumab

object_name: ovarian cancer


subject: UMLS:C2346822

object_name: ovarian neoplasm


subject: UMLS:C2346822


subject: UNII:E6BTT8VA5Z

subject_name: Filorexant

object_name: Primary Insomnia


subject: UMLS:C3896931

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UMLS:C3896931

object_name: B-cell acute lymphoblastic leukemia


subject: UNII:V0Q46LFE6F

object_name: glioblastoma


subject: UNII:V0Q46LFE6F

object_name: Childhood Glioblastoma


subject: UNII:V0Q46LFE6F

object_name: adult glioblastoma


subject: UNII:V0Q46LFE6F

object_name: glioma


subject: UNII:V0Q46LFE6F

object_name: malignant glioma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: PSA Progression


subject: CHEBI:31355

object_name: Adenocarcinoma of the prostate stage IV


subject: CHEBI:31355

object_name: PSA Level Greater than or Equal to Two


subject: CHEBI:31355

object_name: ATM Gene Mutation


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Homologous Recombination Deficiency


subject: CHEBI:4672

object_name: Castration Levels of Testosterone


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:134689

subject_name: Rucaparib


subject: CHEBI:134689

object_name: castration-resistant prostate carcinoma


subject: CHEBI:134689

object_name: Prostate Carcinoma Metastatic in the Bone


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Rhinitis seasonal


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: dystonia


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C4727634

subject_name: CT-053 Tosylate

object_name: non-small cell lung carcinoma


subject: UNII:W9Y8L7GP4C

subject_name: Cetrotide

object_name: ovarian hyperstimulation syndrome


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Seborrhoeic blepharitis


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Carcinoma of urinary bladder, invasive


subject: CHEBI:10093

subject_name: Yohimbine

object_name: impotence


subject: CHEBI:10093

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:10093

object_name: Erectile dysfunction


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: Capillary leak


subject: PR:000002327

object_name: Capillary Leak Syndrome, CTCAE


subject: CHEBI:7772

subject_name: omeprazole

object_name: Hypoalbuminemia, CTCAE


subject: CHEBI:7772

object_name: Serum albumin level decreased below normal (finding)


subject: CHEBI:7772

object_name: Hypoalbuminemia


subject: CHEBI:7772

object_name: Peptic Ulcer Hemorrhage


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: thyroid Hurthle cell carcinoma


subject: CHEBI:75045

object_name: oncocytic adenoma


subject: UMLS:C4053607

object_name: thyroid tumor


subject: UMLS:C4053607

object_name: thyroid cancer


subject: UMLS:C4053607

object_name: thyroid gland papillary carcinoma


subject: UMLS:C4053607

object_name: thyroid gland follicular carcinoma


subject: UMLS:C4053607

object_name: thyroid cancer, nonmedullary, 2


subject: UMLS:C4053607


subject: UMLS:C4053607

object_name: poorly differentiated thyroid gland carcinoma


subject: UMLS:C4053607


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: UMLS:C5667067

subject_name: Anti-CD117/Amanitin Antibody-drug Conjugate MGTA-117

object_name: Myelodysplasia


subject: UMLS:C5667067

object_name: Myelodysplasia, CTCAE


subject: UMLS:C5667067

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5667067

object_name: acute myeloid leukemia


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IB Esophageal Cancer AJCC v7


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601

object_name: Stage IIB Esophageal Carcinoma


subject: CHEBI:231601

object_name: Stage IIA Esophagus Carcinoma


subject: CHEBI:231601

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Blast Phase


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: De Novo Myelodysplastic Syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Secondary Myelodysplastic Syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: acute undifferentiated leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB16568

subject_name: Succinylated gelatin

object_name: Edema


subject: UMLS:C0143961

subject_name: succinylated gelatin


subject: DRUGBANK:DB09106

subject_name: hetastarch

object_name: hypotension


subject: DRUGBANK:DB09106

object_name: Hypotension, CTCAE


subject: DRUGBANK:DB09106

object_name: anesthesia; adverse effect, spinal and epidural


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: osteoarthritis


subject: CHEBI:240107

subject_name: Bromfenac

object_name: eye disorder


subject: CHEBI:240107

object_name: retinal disease


subject: CHEBI:240107

object_name: lens disorder


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: RXCUI:1540230

subject_name: ketorolac 2.88 MG/ML / phenylephrine 10.16 MG/ML Ophthalmic Irrigation Solution

object_name: cataract


subject: RXCUI:1540230

object_name: Cataract, CTCAE 3.0


subject: RXCUI:1540230

object_name: Cataract, CTCAE 5.0


subject: RXCUI:1540230

object_name: cataract on exam (physical finding)


subject: RXCUI:1540230

object_name: Macular Edema


subject: RXCUI:1540230

object_name: cystoid macular edema


subject: RXCUI:1540230


subject: RXCUI:1540230


subject: RXCUI:1540230


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: CD45-Positive Neoplastic Cells Present


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: GTOPDB:12969

subject_name: tarlatamab

object_name: glioma


subject: GTOPDB:12969

object_name: malignant glioma


subject: GTOPDB:12969

object_name: Adult Central Nervous System Neoplasm


subject: GTOPDB:12969

object_name: Childhood Central Nervous System Neoplasm


subject: UNII:74X82ST8Q1

subject_name: TARLATAMAB


subject: UNII:74X82ST8Q1


subject: UNII:74X82ST8Q1


subject: UNII:74X82ST8Q1


subject: UMLS:C4687660

subject_name: AMG 757


subject: UMLS:C4687660


subject: UMLS:C4687660


subject: UMLS:C4687660


subject: CHEBI:231324

subject_name: alpelisib

object_name: Locally advanced breast cancer


subject: PUBCHEM.COMPOUND:146219790

subject_name: atirmociclib

object_name: estrogen-receptor positive breast cancer


subject: PUBCHEM.COMPOUND:146219790

object_name: Her2-receptor negative breast cancer


subject: PUBCHEM.COMPOUND:146219790


subject: UMLS:C5966116

subject_name: Atirmociclib


subject: UMLS:C5966116


subject: UMLS:C5966116


subject: PUBCHEM.COMPOUND:135351887

subject_name: PALAZESTRANT


subject: UNII:VU35KM56Q4


subject: CHEBI:4853

subject_name: Esculin

object_name: presbyopia


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Renal Function


subject: CHEBI:9130

object_name: fluoride poisoning


subject: CHEBI:3699

subject_name: Cimetidine

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:3699

object_name: amyotrophic lateral sclerosis


subject: GTOPDB:13605

subject_name: golodirsen

object_name: Duchenne muscular dystrophy


subject: UNII:033072U4MZ

subject_name: Golodirsen


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C5783010

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C5783010

object_name: chronic myelomonocytic leukemia


subject: CHEBI:185135

subject_name: Polyvidone

object_name: blepharitis


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Phrenic nerve lesion


subject: CHEBI:3509

object_name: Pseudomonas aeruginosa meningitis


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: UMLS:C0021761

object_name: Metastatic urothelial carcinoma


subject: UMLS:C0021761

object_name: Urothelial carcinoma ureter metastatic


subject: UMLS:C0021761

object_name: Metastatic Urethral Urothelial Carcinoma


subject: UMLS:C0021761

object_name: Advanced Ureter Urothelial Carcinoma


subject: UMLS:C0021761

object_name: Advanced Bladder Urothelial Carcinoma


subject: UMLS:C0021761

object_name: Metastatic Bladder Urothelial Carcinoma


subject: UMLS:C0021761

object_name: Urothelial carcinoma ureter recurrent


subject: UMLS:C0021761

object_name: Urothelial carcinoma bladder recurrent


subject: UMLS:C0021761

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: UMLS:C0021761

object_name: Urothelial carcinoma urethra recurrent


subject: UMLS:C0021761

object_name: Unresectable Ureter Urothelial Carcinoma


subject: UMLS:C0021761

object_name: Unresectable Bladder Urothelial Carcinoma


subject: UMLS:C0021761

object_name: Recurrent Renal Pelvis Urothelial Carcinoma


subject: UMLS:C0021761

object_name: Unresectable Renal Pelvis Urothelial Carcinoma


subject: UMLS:C0021761

object_name: Stage IV Urethral Cancer AJCC v8


subject: UMLS:C0021761

object_name: Stage III Urethral Cancer AJCC v8


subject: UMLS:C0021761

object_name: Stage III Ureter Cancer AJCC v8


subject: UMLS:C0021761

object_name: Stage IV Ureter Cancer AJCC v8


subject: UMLS:C0021761

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C0021761

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: UMLS:C0021761

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: UMLS:C0021761

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C0021761

object_name: Stage IVA Bladder Cancer AJCC v8


subject: UMLS:C0021761

object_name: Stage IVB Bladder Cancer AJCC v8


subject: UMLS:C2697511

object_name: Metastatic urothelial carcinoma


subject: UMLS:C2697511

object_name: Urothelial carcinoma ureter metastatic


subject: UMLS:C2697511

object_name: Metastatic Urethral Urothelial Carcinoma


subject: UMLS:C2697511

object_name: Advanced Ureter Urothelial Carcinoma


subject: UMLS:C2697511

object_name: Advanced Bladder Urothelial Carcinoma


subject: UMLS:C2697511

object_name: Metastatic Bladder Urothelial Carcinoma


subject: UMLS:C2697511

object_name: Urothelial carcinoma ureter recurrent


subject: UMLS:C2697511

object_name: Urothelial carcinoma bladder recurrent


subject: UMLS:C2697511

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: UMLS:C2697511

object_name: Urothelial carcinoma urethra recurrent


subject: UMLS:C2697511

object_name: Unresectable Ureter Urothelial Carcinoma


subject: UMLS:C2697511

object_name: Unresectable Bladder Urothelial Carcinoma


subject: UMLS:C2697511

object_name: Recurrent Renal Pelvis Urothelial Carcinoma


subject: UMLS:C2697511

object_name: Unresectable Renal Pelvis Urothelial Carcinoma


subject: UMLS:C2697511

object_name: Stage IV Urethral Cancer AJCC v8


subject: UMLS:C2697511

object_name: Stage III Urethral Cancer AJCC v8


subject: UMLS:C2697511

object_name: Stage III Ureter Cancer AJCC v8


subject: UMLS:C2697511

object_name: Stage IV Ureter Cancer AJCC v8


subject: UMLS:C2697511

object_name: Stage III Bladder Cancer AJCC v8


subject: UMLS:C2697511

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: UMLS:C2697511

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: UMLS:C2697511

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C2697511

object_name: Stage IVA Bladder Cancer AJCC v8


subject: UMLS:C2697511

object_name: Stage IVB Bladder Cancer AJCC v8


subject: CHEBI:151315

subject_name: Heparin

object_name: Thrombophilia Related to COVID-19


subject: CHEBI:151315

object_name: thrombophilia


subject: KEGG.COMPOUND:C00374

object_name: Pregnant


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: CHEMBL.COMPOUND:CHEMBL4594477

object_name: asthma


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: endometrial hyperplasia without atypia


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Anterior epistaxis


subject: MESH:C586932

subject_name: colloidal silver

object_name: severe acute respiratory syndrome


subject: CHEBI:30512

subject_name: Silver


subject: CHEBI:49468

subject_name: Silver cation


subject: UNII:667440B6Z7

object_name: cocaine dependence


subject: PUBCHEM.COMPOUND:44560493


subject: UMLS:C3502022

subject_name: RTI 336


subject: UNII:9G2MP84A8W

object_name: brain neoplasm


subject: UNII:9G2MP84A8W

object_name: Neoplasm Metastasis


subject: CHEBI:137245

subject_name: Asp-Pro

object_name: HIV infection


subject: CHEBI:194539

subject_name: tennessine atom


subject: CHEBI:169954

subject_name: Thr-Ser


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: transitional cell carcinoma


subject: GTOPDB:11376

object_name: bladder tumor


subject: GTOPDB:11376

object_name: urinary bladder carcinoma


subject: GTOPDB:11376

object_name: urinary bladder cancer


subject: GTOPDB:11376

object_name: childhood bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: blood coagulation disease


subject: CHEBI:38290

object_name: Hospital acquired pneumonia


subject: CHEBI:38290

object_name: Healthcare associated pneumonia


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:109530

subject_name: TRIM

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: CHEBI:109530

object_name: abscess


subject: UMLS:C0146783

subject_name: trim resin


subject: UMLS:C0146783


subject: PR:000016620

subject_name: T-cell receptor-associated transmembrane adapter 1


subject: PR:000016620


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: T-cell lymphoma recurrent


subject: CHEBI:201431

object_name: Mantle cell lymphoma refractory


subject: CHEBI:201431

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:201431


subject: CHEBI:201431

object_name: Follicular lymphoma recurrent


subject: CHEBI:201431

object_name: Indolent Non-Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UNII:CS4U38E731

subject_name: Nigella sativa oil

object_name: periodontitis, chronic, adult


subject: UNII:CS4U38E731

object_name: chronic periodontitis


subject: CHEBI:233453

object_name: bacterial vaginosis


subject: CHEBI:35854

subject_name: Valaciclovir


subject: UMLS:C2981820

object_name: Childhood Solid Neoplasm


subject: UMLS:C2981820

object_name: Adult Solid Neoplasm


subject: CHEBI:145373

subject_name: Pexidartinib


subject: CHEBI:145373


subject: UNII:12WJ62D047

subject_name: Verinurad

object_name: gout


subject: UMLS:C4743015


subject: CHEBI:75551

object_name: cystic fibrosis


subject: UNII:8QR88H79VX

subject_name: Mivavotinib

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:8QR88H79VX

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:8QR88H79VX

object_name: Refractory Ovarian Carcinoma


subject: UNII:8QR88H79VX

object_name: ovarian cancer


subject: UNII:8QR88H79VX

object_name: ovarian carcinoma


subject: UNII:8QR88H79VX

object_name: malignant epithelial tumor of ovary


subject: CHEBI:8378

subject_name: Prednisolone

object_name: function of renal transplant


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:95165

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:50131

subject_name: Decitabine


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Cognitive impairment associated with schizophrenia


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: uveal melanoma


subject: UMLS:C1527137

object_name: medium/large size posterior uveal melanoma


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UMLS:C0305066

subject_name: Human rabies vaccines

object_name: rabies


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: bacterial infectious disease


subject: UNII:17R794ESYN

subject_name: PENICILLIN G PROCAINE


subject: UNII:17R794ESYN

object_name: Sepsis


subject: UNII:17R794ESYN

object_name: Sepsis, CTCAE


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:17334


subject: CHEBI:17334


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: RXCUI:151399

subject_name: Bactrim


subject: RXCUI:151399


subject: RXCUI:151399


subject: CHEBI:32150

object_name: malignant soft tissue neoplasm


subject: CHEBI:32150

object_name: sarcoma


subject: CHEBI:32150

object_name: Childhood Neuroblastoma


subject: CHEBI:32150

object_name: neuroblastoma


subject: CHEBI:32150

object_name: childhood germ cell tumor


subject: CHEBI:32150

object_name: extragonadal germ cell tumor


subject: CHEBI:32150

object_name: brain neoplasm


subject: CHEBI:32150

object_name: central nervous system neoplasm


subject: CHEBI:32150

object_name: central nervous system cancer


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:49960

subject_name: Vandetanib

object_name: transitional cell carcinoma


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: digestive system cancer


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: no feeling or sensation of skin


subject: UMLS:C0013227

object_name: Sensory Loss


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4026

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4026

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4026

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4026

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:168396

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UNII:49X2Q41T99

subject_name: PEGSITACIANINE

object_name: Neck Carcinoma


subject: UNII:49X2Q41T99

object_name: head and neck neoplasm


subject: UNII:49X2Q41T99

object_name: head and neck cancer


subject: UNII:49X2Q41T99

object_name: cancer of unknown primary site


subject: UNII:49X2Q41T99

object_name: head and neck squamous cell carcinoma


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: non-small cell squamous lung carcinoma


subject: MESH:C000722208

subject_name: LY3295668 erbumine

object_name: Childhood Neuroblastoma


subject: MESH:C000722208

object_name: neuroblastoma


subject: UMLS:C2703094

object_name: Advanced renal cell carcinoma


subject: UMLS:C2703094

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C2703094

object_name: Metastatic Renal Cell Cancer


subject: MESH:D022261

subject_name: Respiratory Syncytial Virus Vaccines

object_name: Pregnant


subject: UMLS:C4537797

subject_name: Tdap vaccine administration


subject: UMLS:C4537797

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Stress Fracture


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: mixed anxiety and depressive disorder


subject: CHEBI:16581

object_name: HIV infection


subject: UMLS:C4053637

object_name: neoplasm


subject: CHEBI:3207

subject_name: Budesonide

object_name: Inflammation


subject: CHEBI:3207

object_name: respiratory system disorder


subject: CHEBI:3207

object_name: Allergy


subject: CHEBI:3207

object_name: hypersensitivity reaction disease


subject: CHEBI:3207

object_name: Emotional hypersensitivity


subject: CHEBI:3310

subject_name: Calcium acetate

object_name: kidney failure


subject: UMLS:C1704298

subject_name: Recombinant Luteinizing Hormone

object_name: ovarian reserve


subject: CHEBI:36791

subject_name: Escitalopram

object_name: lung cancer


subject: CHEBI:36791

object_name: lung neoplasm


subject: CHEBI:36791

object_name: lung carcinoma


subject: CHEBI:36791

object_name: colorectal cancer


subject: CHEBI:36791

object_name: colorectal carcinoma


subject: CHEBI:36791

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:36791

object_name: carcinoma of esophagus


subject: CHEBI:36791

object_name: esophageal cancer


subject: CHEBI:36791

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:36791

object_name: neoplasm of esophagus


subject: CHEBI:36791

object_name: Stomach cancer


subject: CHEBI:36791

object_name: gastric cancer


subject: CHEBI:36791

object_name: liver cancer


subject: CHEBI:36791

object_name: liver neoplasm


subject: CHEBI:36791

object_name: Adult Liver Carcinoma


subject: CHEBI:36791

object_name: liver carcinoma


subject: CHEBI:36791

object_name: pancreatic neoplasm


subject: CHEBI:36791

object_name: exocrine pancreatic carcinoma


subject: CHEBI:36791

object_name: malignant pancreatic neoplasm


subject: CHEBI:36791

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:36791

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:36791

object_name: gallbladder cancer


subject: CHEBI:36791

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:36791

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:36791

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:36791

object_name: gallbladder carcinoma


subject: CHEBI:36791

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:36791

object_name: malignant tumor of extrahepatic bile duct


subject: CHEBI:36791

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:36791

object_name: Fatigue


subject: CHEBI:3723

subject_name: Citalopram

object_name: lung cancer


subject: CHEBI:3723

object_name: lung neoplasm


subject: CHEBI:3723

object_name: lung carcinoma


subject: CHEBI:3723

object_name: colorectal cancer


subject: CHEBI:3723

object_name: colorectal carcinoma


subject: CHEBI:3723

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:3723

object_name: carcinoma of esophagus


subject: CHEBI:3723

object_name: esophageal cancer


subject: CHEBI:3723

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:3723

object_name: neoplasm of esophagus


subject: CHEBI:3723

object_name: Stomach cancer


subject: CHEBI:3723

object_name: gastric cancer


subject: CHEBI:3723

object_name: liver cancer


subject: CHEBI:3723

object_name: liver neoplasm


subject: CHEBI:3723

object_name: Adult Liver Carcinoma


subject: CHEBI:3723

object_name: liver carcinoma


subject: CHEBI:3723

object_name: pancreatic neoplasm


subject: CHEBI:3723

object_name: exocrine pancreatic carcinoma


subject: CHEBI:3723

object_name: malignant pancreatic neoplasm


subject: CHEBI:3723

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:3723

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:3723

object_name: gallbladder cancer


subject: CHEBI:3723

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:3723

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:3723

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:3723

object_name: gallbladder carcinoma


subject: CHEBI:3723

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:3723

object_name: malignant tumor of extrahepatic bile duct


subject: CHEBI:3723

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:3723

object_name: Fatigue


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: gastroparesis


subject: CHEBI:71196

object_name: Delayed gastric emptying


subject: CHEBI:71196

object_name: morbid obesity


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: high grade B-cell lymphoma


subject: UNII:5S371K6132

object_name: ALK-positive anaplastic large cell lymphoma


subject: UNII:5S371K6132

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: UNII:5S371K6132

object_name: grade 3B follicular lymphoma


subject: UNII:5S371K6132

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: GTOPDB:9758

subject_name: camrelizumab


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:6SN82Y9U73

subject_name: FORODESINE HYDROCHLORIDE

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1997549

subject_name: Forodesine hydrochloride


subject: UMLS:C1175653


subject: CHEBI:41423

subject_name: Celecoxib

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:78825

subject_name: Avutometinib

object_name: pancreatic adenocarcinoma


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:39548

object_name: subarachnoid hemorrhage


subject: CHEBI:32696

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:32696

object_name: COPD, severe early onset


subject: CHEBI:32696

object_name: chronic obstructive pulmonary disease


subject: CHEBI:32696

object_name: Dyspnea


subject: CHEBI:32696

object_name: Dyspnea, CTCAE


subject: CHEBI:32696

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:32696

object_name: Argininemia


subject: CHEBI:32696

object_name: Hyperargininemia


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: UNII:1B56C968OA

subject_name: Becaplermin

object_name: diabetic foot


subject: UNII:1B56C968OA

object_name: Foot Ulcer


subject: UNII:1B56C968OA

object_name: Skin ulcer


subject: UNII:1B56C968OA

object_name: diabetic neuropathy


subject: PR:000012491

subject_name: platelet-derived growth factor subunit B


subject: PR:000012491


subject: PR:000012491


subject: PR:000012491


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: aneuploidy


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Exon Mutation


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:136133795

subject_name: Formyltetrahydrofolate

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:136133795

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:136133795

object_name: Childhood Rectal Carcinoma


subject: PUBCHEM.COMPOUND:136133795

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:136133795

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:136133795

object_name: colon cancer


subject: PUBCHEM.COMPOUND:136133795


subject: PUBCHEM.COMPOUND:136133795

object_name: thyroid gland papillary carcinoma


subject: PUBCHEM.COMPOUND:136133795

object_name: Effects of chemotherapy


subject: MESH:D005575

subject_name: Formyltetrahydrofolates


subject: MESH:D005575


subject: MESH:D005575


subject: MESH:D005575


subject: MESH:D005575


subject: MESH:D005575


subject: MESH:D005575


subject: MESH:D005575


subject: MESH:D005575


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR

object_name: Complications of transplanted heart


subject: CHEBI:132975

subject_name: Grazoprevir


subject: PUBCHEM.COMPOUND:166177193

object_name: leukoencephalopathy with vanishing white matter 5


subject: PUBCHEM.COMPOUND:166177193

object_name: leukoencephalopathy with vanishing white matter


subject: PUBCHEM.COMPOUND:166177193

object_name: leukoencephalopathy with vanishing white matter 1


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: postmenopausal osteoporosis


subject: CHEBI:71196

object_name: osteoporosis


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: UMLS:C2917359


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: Myelodysplasia


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: UMLS:C1831949


subject: PUBCHEM.COMPOUND:62957

subject_name: Oviol

object_name: infertility


subject: UMLS:C0678132

subject_name: Marvelon


subject: CHEBI:71032

subject_name: Phe-Ser

object_name: Upper gastrointestinal hemorrhage


subject: UMLS:C3653731

subject_name: ANTI-ACNE PREPARATIONS FOR TOPICAL USE

object_name: acne


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: MESH:C527600

subject_name: Arista

object_name: Intraoperative Hemorrhage


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: heart failure


subject: CHEBI:28787

object_name: Heart Failure, CTCAE


subject: DRUGBANK:DB19013

subject_name: Insulin efsitora alfa

object_name: Type 2 diabetes treated with insulin


subject: CHEBI:33364

subject_name: Platinum

object_name: Metastatic non-small cell lung cancer


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: low grade glioma


subject: CHEBI:134703

object_name: Low grade glioma of brain


subject: CHEBI:134703

object_name: Intracranial glioma


subject: CHEBI:37924

subject_name: Atazanavir

object_name: HIV-Associated Lipodystrophy Syndrome


subject: UNII:N24015WC6D

subject_name: Atevirdine


subject: CHEBI:45409

subject_name: Ritonavir


subject: GTOPDB:12969

subject_name: tarlatamab

object_name: Small cell lung cancer limited stage


subject: UNII:74X82ST8Q1

subject_name: TARLATAMAB


subject: UMLS:C4687660

subject_name: AMG 757


subject: UMLS:C5417984

subject_name: MEK Inhibitor HL-085

object_name: plexiform neurofibroma


subject: UMLS:C5417984

object_name: neurofibromatosis 1


subject: UMLS:C5417984

object_name: neurofibromatosis type 1


subject: UMLS:C0306371

subject_name: Humulin R

object_name: Surgical Wound Infection


subject: UMLS:C0306371

object_name: respiratory failure


subject: UMLS:C0306371

object_name: Respiratory Failure, CTCAE


subject: UMLS:C0306371

object_name: kidney failure


subject: UMLS:C0306371

object_name: Renal Failure, CTCAE


subject: UMLS:C0306371

object_name: Sepsis


subject: UMLS:C0306371

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:126843196

subject_name: Recombinant insulin Human


subject: PUBCHEM.COMPOUND:126843196


subject: PUBCHEM.COMPOUND:126843196


subject: PUBCHEM.COMPOUND:126843196


subject: PUBCHEM.COMPOUND:126843196


subject: PUBCHEM.COMPOUND:126843196


subject: PUBCHEM.COMPOUND:126843196


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: UMLS:C1446598

subject_name: Recombinant human regular insulin


subject: UMLS:C1446598


subject: UMLS:C1446598


subject: UMLS:C1446598


subject: UMLS:C1446598


subject: UMLS:C1446598


subject: UMLS:C1446598


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Hypoxemia


subject: CHEBI:73604

object_name: Hypoxia, CTCAE


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: High grade glioma


subject: UNII:16VY3TM7ZO

object_name: malignant glioma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: CHEBI:17553

object_name: Low back pain


subject: CHEBI:71464

subject_name: Palmidrol


subject: UMLS:C1572795

subject_name: PEA Preparation


subject: CHEBI:18397

subject_name: Phenethylamine


subject: DRUGBANK:DB10551

subject_name: Pea


subject: UNII:T61871RKRI

object_name: neoplasm


subject: CHEBI:15727

subject_name: Carnosine

object_name: Heart Disease Risk Factors


subject: CHEBI:15727


subject: CHEBI:15727

object_name: Poor glycemic control


subject: UMLS:C0007267

subject_name: carnosine


subject: UMLS:C0007267


subject: UMLS:C0007267


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: diabetic kidney disease


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UNII:P050J5FWC5

subject_name: INTERFERON GAMMA

object_name: pulmonary tuberculosis


subject: UNII:P050J5FWC5

object_name: pneumonia


subject: UNII:P050J5FWC5

object_name: COVID-19-Associated Pneumonia


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: psoriatic arthritis


subject: PUBCHEM.COMPOUND:155543961

object_name: psoriasis


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C2745432

subject_name: Meditoxin

object_name: Urinary Urgency


subject: CHEBI:6965

subject_name: Molindone

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: ST-elevation myocardial infarction


subject: CHEBI:28821

subject_name: Piperine


subject: CHEBI:25805

subject_name: oxygen atom

object_name: coronary microvascular disorder


subject: CHEBI:25805

object_name: decompression sickness


subject: CHEBI:15379

subject_name: Oxygen


subject: GTOPDB:5962

subject_name: dovitinib

object_name: liver carcinoma


subject: UMLS:C5854399

object_name: post-traumatic stress disorder


subject: UMLS:C5854399

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: multiple sclerosis


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Cutaneous T-cell lymphoma stage I


subject: PUBCHEM.COMPOUND:73005958

object_name: Cutaneous T-cell lymphoma stage IV


subject: PUBCHEM.COMPOUND:73005958

object_name: Cutaneous T-cell lymphoma stage II


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:73005958

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: recurrent cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:73005958

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:73005958

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:61080

subject_name: Romidepsin


subject: CHEBI:61080


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:71940

subject_name: Tadalafil

object_name: plasma cell myeloma


subject: CHEMBL.COMPOUND:CHEMBL4594467

object_name: psoriasis


subject: UMLS:C1705207

subject_name: Endostar

object_name: metastatic malignant neoplasm in the brain


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: penis carcinoma


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: UMLS:C5854527

subject_name: Anti-PD-L1 Antibody/IL-15 Fusion Protein IGM-7354

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854527

object_name: Adult Solid Neoplasm


subject: UMLS:C5854527

object_name: Solid Neoplasm


subject: CHEBI:90748

object_name: Kaposi Sarcoma


subject: CHEBI:90748

object_name: HIV infection


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Dyspnea


subject: CHEBI:87681

object_name: Dyspnea, CTCAE


subject: CHEBI:87681

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:87681

object_name: Chest pain


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Critical Illness


subject: CHEBI:93862

object_name: Genital warts


subject: CHEBI:64213

subject_name: Cantharidin


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Mesothelioma


subject: CHEBI:93775

object_name: mesothelial neoplasm


subject: CHEBI:93775

object_name: malignant mesothelioma


subject: CHEBI:93775

object_name: malignant pleural mesothelioma


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: GTOPDB:12652

subject_name: magrolimab

object_name: non-Hodgkin lymphoma


subject: UNII:90YIEHRFJ9


subject: PUBCHEM.COMPOUND:44198096

subject_name: DUTOGLIPTIN TARTRATE

object_name: acute myocardial infarction


subject: PUBCHEM.COMPOUND:44198096

object_name: Acute Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:44198096

object_name: ST-elevation myocardial infarction


subject: PUBCHEM.COMPOUND:44198096

object_name: Acute myocardial ischemia


subject: UMLS:C2828327

subject_name: Dutogliptin Tartrate


subject: UMLS:C2828327


subject: UMLS:C2828327


subject: UMLS:C2828327


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: CHEBI:71223

subject_name: Pralatrexate

object_name: T-cell lymphoma refractory


subject: UMLS:C5814454

subject_name: Arexvy

object_name: Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:681848

subject_name: Doxapram

object_name: Sedation


subject: CHEBI:681848

object_name: Sedated


subject: CHEBI:681848

object_name: Hypoxemia


subject: CHEBI:681848

object_name: Hypoxia, CTCAE


subject: CHEBI:23965

subject_name: estradiol

object_name: Vasomotor menopausal symptoms


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: coronary artery disorder


subject: CHEBI:5494

object_name: coronary atherosclerosis


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:94449


subject: CHEBI:7514

subject_name: Neostigmine


subject: CHEBI:7514


subject: CHEBI:8884

subject_name: Rocuronium


subject: CHEBI:8884


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: PUBCHEM.COMPOUND:74030550


subject: UNII:7R7G6EH5UL

subject_name: Navtemadlin

object_name: non-small cell lung carcinoma


subject: CHEBI:63632

subject_name: Topotecan


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Childhood Breast Carcinoma


subject: UNII:71M78END5S

object_name: breast carcinoma


subject: UNII:71M78END5S

object_name: breast cancer


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: acute leukemia


subject: UNII:39IS23Q1EW

object_name: acute undifferentiated leukemia


subject: DRUGBANK:DB06181

object_name: head and neck squamous cell carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: HELLP syndrome


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Adult Burkitt Lymphoma


subject: CHEBI:31355

object_name: primary mediastinal large B-cell lymphoma


subject: CHEBI:31355

object_name: Lymphoma, Large-Cell, Follicular


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UMLS:C0459821

subject_name: pumpkin seed extract

object_name: metabolic disease


subject: UMLS:C0459821

object_name: type 2 diabetes mellitus


subject: UMLS:C0459821

object_name: Diabetes


subject: UMLS:C0459821

object_name: diabetes mellitus


subject: UNII:Z9U2SS9ZC8

object_name: breast neoplasm


subject: UMLS:C2703165


subject: CHEBI:31401

subject_name: Cilostazol

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:5L84K4IEN9

object_name: migraine


subject: UNII:5L84K4IEN9

object_name: migraine with or without aura, susceptibility to, 1


subject: DRUGBANK:DB19282

subject_name: Lacticaseibacillus rhamnosus

object_name: pneumonitis


subject: DRUGBANK:DB19282

object_name: pneumonia


subject: DRUGBANK:DB19282

object_name: cystic fibrosis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Opioid withdrawal


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:71M78END5S

object_name: prostate carcinoma


subject: UNII:71M78END5S

object_name: prostate cancer


subject: CHEBI:33355

subject_name: bohrium atom

object_name: traumatic encephalopathy


subject: CHEBI:33355

object_name: traumatic brain injury


subject: CHEBI:33349

subject_name: dubnium atom


subject: CHEBI:33349


subject: CHEBI:73426

subject_name: Asn-Ser


subject: CHEBI:73426


subject: PR:000008117

subject_name: guanine nucleotide-binding protein-like 3


subject: PR:000008117


subject: UMLS:C2348691

subject_name: Fluorine F-18 HX4

object_name: Neck Carcinoma


subject: UMLS:C2348691

object_name: head and neck neoplasm


subject: UMLS:C2348691

object_name: head and neck cancer


subject: UMLS:C2348691

object_name: liver cancer


subject: UMLS:C2348691

object_name: liver neoplasm


subject: UMLS:C2348691

object_name: Adult Liver Carcinoma


subject: UMLS:C2348691

object_name: liver carcinoma


subject: UMLS:C2348691

object_name: lung cancer


subject: UMLS:C2348691

object_name: lung neoplasm


subject: UMLS:C2348691

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: anxiety


subject: PUBCHEM.COMPOUND:57414794

object_name: anxiety disorder


subject: PUBCHEM.COMPOUND:57414794

object_name: Anxiety symptoms


subject: PUBCHEM.COMPOUND:57414794

object_name: Anxiety, CTCAE 3.0


subject: PUBCHEM.COMPOUND:57414794

object_name: Anxiety, CTCAE 5.0


subject: PUBCHEM.COMPOUND:57414794

object_name: insomnia


subject: PUBCHEM.COMPOUND:57414794

object_name: Insomnia, CTCAE 3.0


subject: PUBCHEM.COMPOUND:57414794

object_name: Insomnia, CTCAE 5.0


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UNII:8D7B37T28G

subject_name: SATRAPLATIN

object_name: non-small cell lung carcinoma


subject: UMLS:C5706383

subject_name: Anti-TIGIT Monoclonal Antibody JS006

object_name: cancer


subject: UMLS:C4079949

object_name: melanoma


subject: CHEBI:94531

subject_name: belinostat

object_name: peritoneum cancer


subject: CHEBI:94531

object_name: ovarian seromucinous carcinoma


subject: CHEBI:94531

object_name: ovarian Brenner tumor


subject: CHEBI:94531

object_name: Brenner tumor


subject: CHEBI:94531

object_name: ovarian undifferentiated adenocarcinoma


subject: CHEBI:94531

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:94531

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:94531

object_name: ovarian serous cystadenocarcinoma


subject: CHEBI:94531

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:74705

subject_name: Met-Leu

object_name: developmental and epileptic encephalopathy


subject: CHEBI:74705

object_name: West syndrome


subject: CHEBI:74705

object_name: Infantile Spasm


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: CHEMBL.COMPOUND:CHEMBL4297804


subject: CHEMBL.COMPOUND:CHEMBL4297804

object_name: breast neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297804

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL4297804

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297804

object_name: neoplasm


subject: UMLS:C3827089

object_name: non-small cell lung carcinoma


subject: UMLS:C3827089


subject: UMLS:C3827089


subject: UMLS:C3827089


subject: UMLS:C3827089


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: rectal carcinoma


subject: UNII:W0ZE0NT8IF

object_name: rectal cancer


subject: UNII:W0ZE0NT8IF

object_name: Childhood Rectal Carcinoma


subject: UMLS:C5204531

subject_name: A2AR/A2BR Antagonist AB928


subject: UMLS:C5204531


subject: UMLS:C5204531


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: CHEBI:63660

object_name: Childhood Breast Carcinoma


subject: CHEBI:63660

object_name: breast cancer


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: UNII:6N79I7X5II

subject_name: VALEMETOSTAT TOSYLATE

object_name: lung cancer


subject: UNII:6N79I7X5II

object_name: lung neoplasm


subject: UNII:6N79I7X5II

object_name: lung carcinoma


subject: UNII:6N79I7X5II


subject: UMLS:C5238968

subject_name: Valemetostat Tosylate


subject: UMLS:C5238968


subject: UMLS:C5238968


subject: UMLS:C5238968


subject: UMLS:C2700362

subject_name: Lymphoseek

object_name: Neck Carcinoma


subject: UMLS:C2700362

object_name: head and neck neoplasm


subject: UMLS:C2700362

object_name: head and neck cancer


subject: UMLS:C2700362

object_name: head and neck squamous cell carcinoma


subject: CHEBI:32696

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:32696

object_name: mitochondrial disease


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16349

subject_name: Citrulline


subject: CHEBI:16349


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: essential thrombocythemia


subject: CHEBI:141969

object_name: acquired polycythemia vera


subject: CHEBI:141969

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:121489720

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Metastatic Castration-Sensitive Prostate Carcinoma


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:29947

subject_name: glycine residue

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: CHEBI:29947

object_name: viral pneumonia


subject: CHEBI:29947

object_name: severe acute respiratory syndrome


subject: CHEBI:29947

object_name: acute respiratory distress syndrome


subject: CHEBI:15428

subject_name: Glycine


subject: CHEBI:15428


subject: CHEBI:15428


subject: CHEBI:15428


subject: CHEBI:91400

subject_name: Afatinib

object_name: digestive system neoplasm


subject: CHEBI:91400

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:91400

object_name: pancreatic neoplasm


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:27470

subject_name: Folic acid

object_name: Deep venous thrombosis


subject: CHEBI:27470

object_name: pulmonary embolism


subject: UMLS:C5854509

subject_name: ADC 9MW2821

object_name: bladder tumor


subject: UMLS:C5854509

object_name: urinary bladder carcinoma


subject: UMLS:C5854509

object_name: urinary bladder cancer


subject: UMLS:C5854509

object_name: childhood bladder carcinoma


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: urinary tract infection


subject: CHEBI:38290

object_name: bacterial urinary tract infection


subject: CHEBI:38290

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:38290

object_name: spinal cord injury


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:2955

subject_name: Azithromycin

object_name: Caesarean section


subject: CHEBI:2955

object_name: Complication of labor and delivery, unspecified


subject: CHEBI:2955

object_name: Obstetric disorders


subject: CHEBI:2955

object_name: Complications of pregnancy, childbirth and the puerperium


subject: CHEBI:48843

subject_name: sodium selenite

object_name: Treatment Resistant Disorders


subject: CHEBI:48843

object_name: cancer


subject: CHEBI:48843

object_name: Tumor Progression


subject: CHEBI:63630

subject_name: Tolcapone

object_name: Impulsivity


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: dengue disease


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: Raynaud disease


subject: UMLS:C4743433

object_name: scleroderma


subject: UMLS:C4743433

object_name: systemic sclerosis


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: Partial Response of Multiple Myeloma or Plasma Cell Leukemia


subject: DRUGBANK:DB17475

object_name: plasma cell myeloma


subject: CHEBI:63791

subject_name: Lenalidomide


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: CHEMBL.COMPOUND:CHEMBL1200460

subject_name: FERRIC AMMONIUM CITRATE

object_name: iron deficiency anemia


subject: CHEMBL.COMPOUND:CHEMBL1200460

object_name: Gastrointestinal hemorrhage


subject: CHEBI:31604

subject_name: ferric ammonium citrate


subject: CHEBI:31604


subject: UNII:UVP74NG1C5

subject_name: FerriSeltz


subject: UNII:UVP74NG1C5


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: factor VIII measurement


subject: PUBCHEM.COMPOUND:27991

object_name: mild hemophilia A


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: CHEBI:45783

subject_name: Imatinib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:45783

object_name: clear cell renal carcinoma


subject: CHEBI:28976

subject_name: carbonic acid

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:28976

object_name: metabolic syndrome X


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C1258613

object_name: cardiotoxicity


subject: CHEBI:94573

subject_name: Zibotentan


subject: CHEBI:94573


subject: CHEBI:94573

object_name: Scleroderma renal crisis


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:57503849

subject_name: Hydroxypropylmethylcellulose

object_name: Ocular surface disease


subject: PUBCHEM.COMPOUND:57503849

object_name: Ocular Surface Disease, CTCAE


subject: PUBCHEM.COMPOUND:57503849

object_name: glaucoma


subject: PUBCHEM.COMPOUND:57503849

object_name: Glaucoma, CTCAE


subject: UNII:B1QE5P712K

subject_name: hypromellose 2208 (100 MPA.S)


subject: UNII:B1QE5P712K


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:150712


subject: CHEBI:50692

subject_name: Mifepristone

object_name: alcohol abuse


subject: CHEBI:50692

object_name: alcohol dependence


subject: UMLS:C0935801

subject_name: Carcinoembryonic Antigen Peptide 1-6D

object_name: pancreatic adenocarcinoma


subject: CHEBI:73044

subject_name: Lumiracoxib

object_name: Controlled hypertension


subject: UNII:TT3345YXVR

subject_name: Verdiperstat

object_name: Multiple system atrophy, cerebellar variant


subject: UNII:TT3345YXVR

object_name: Multiple system atrophy (MSA) with orthostatic hypotension


subject: UNII:TT3345YXVR

object_name: Multiple system atrophy, Parkinson's variant


subject: UNII:41TIZ5663Z


subject: UNII:41TIZ5663Z


subject: UNII:41TIZ5663Z


subject: CHEBI:45783

object_name: B-cell chronic lymphocytic leukemia


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: ADHF


subject: CHEMBL.COMPOUND:CHEMBL2108572

subject_name: BALUGRASTIM

object_name: Chemotherapy induced neutropenia


subject: UMLS:C3871462

subject_name: balugrastim


subject: UMLS:C5959687

subject_name: Anti-Siglec-10 Monoclonal Antibody ONC-841

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C3253111

object_name: Neck Carcinoma


subject: UMLS:C3253111

object_name: head and neck neoplasm


subject: UMLS:C3253111

object_name: head and neck cancer


subject: CHEBI:87681

subject_name: Ranolazine

object_name: hypertrophic cardiomyopathy


subject: CHEBI:87681

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:7820

subject_name: Oxandrolone

object_name: hypoplastic left heart syndrome


subject: CHEBI:7820

object_name: congenital heart disease


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:7915

object_name: obesity


subject: CHEBI:7915

object_name: Obesity, CTCAE


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: Disseminated leishmaniasis


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: UNII:LDJ89SS0YG

object_name: Lymphoma, Mixed-Cell, Follicular


subject: UNII:LDJ89SS0YG

object_name: grade 3A follicular lymphoma


subject: UNII:LDJ89SS0YG

object_name: Follicular lymphoma stage II


subject: UNII:LDJ89SS0YG

object_name: Marginal zone lymphoma stage II


subject: UNII:LDJ89SS0YG

object_name: Marginal zone lymphoma stage III


subject: UNII:LDJ89SS0YG

object_name: Follicular lymphoma stage III


subject: UNII:LDJ89SS0YG

object_name: Marginal zone lymphoma stage IV


subject: UNII:LDJ89SS0YG

object_name: Follicle centre lymphoma, follicular grade I, II, III stage IV


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:38940

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:38940

object_name: Carcinoma of the prostate stage III


subject: CHEBI:38940

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:38940

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:38940

object_name: Prostate cancer stage I


subject: CHEBI:38940

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:38940

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:38940

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:38940

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:38940

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:38940

object_name: prostate adenocarcinoma


subject: UMLS:C5235868

object_name: Nasopharyngeal Carcinoma by AJCC v8 Stage


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C1618891

subject_name: Injection, azacitidine, 1 mg administered

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C1618891

object_name: acute biphenotypic leukemia


subject: UMLS:C1618891

object_name: mixed phenotype acute leukemia


subject: UMLS:C1618891

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: UMLS:C4329329

object_name: Advanced gastric carcinoma


subject: UMLS:C4723695

subject_name: penpulimab

object_name: HER2-positive gastric cancer


subject: UMLS:C4723695


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:8774

subject_name: Ramipril

object_name: atrial flutter


subject: CHEBI:8774

object_name: Atrial Flutter by ECG Finding


subject: CHEBI:8774

object_name: Atrial Flutter, CTCAE


subject: CHEBI:8774

object_name: atrial fibrillation


subject: CHEBI:8774

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:8774

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Pelvis fracture


subject: CHEBI:41879

object_name: Hip Fracture, CTCAE


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Sedation


subject: CHEBI:10023

object_name: Sedated


subject: CHEBI:10023

object_name: no feeling or sensation of skin


subject: CHEBI:10023

object_name: Sensory Loss


subject: UMLS:C5565460

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C5565460

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C4053962

subject_name: Synthetic Hypericin


subject: UMLS:C4053962


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Post transplant Epstein-Barr virus associated lymphoproliferative disorder


subject: UNII:4F4X42SYQ6

object_name: Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder


subject: UNII:4F4X42SYQ6

object_name: Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder


subject: UNII:4F4X42SYQ6

object_name: Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder


subject: UNII:4F4X42SYQ6

object_name: Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:90881

subject_name: Camptosar

object_name: non-small cell lung carcinoma


subject: UMLS:C4760648


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: rosacea


subject: UMLS:C0947603

subject_name: FUDR brand of floxuridine

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C5418047

object_name: Solid Neoplasm


subject: UMLS:C5418047

object_name: cancer


subject: UMLS:C5418047

object_name: neoplasm


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: uterine cancer


subject: UNII:5S371K6132

object_name: tumor of uterus


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4086713

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4086713

object_name: sarcoma


subject: UMLS:C4086713

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4086713

object_name: soft tissue sarcoma


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: CHEBI:66964

subject_name: Dronabinol

object_name: HIV infection


subject: UMLS:C1328123

subject_name: Allogeneic Tumor Cell Vaccine

object_name: malignant pleural mesothelioma


subject: UMLS:C1328123

object_name: type C thymoma


subject: UMLS:C1328123

object_name: carcinoma of esophagus


subject: UMLS:C1328123

object_name: esophageal cancer


subject: UMLS:C1328123

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C1328123

object_name: neoplasm of esophagus


subject: UMLS:C1328123

object_name: lung cancer


subject: UMLS:C1328123

object_name: lung neoplasm


subject: UMLS:C1328123

object_name: lung carcinoma


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Bradycardia by ECG Finding


subject: CHEBI:3215

object_name: Bradycardia


subject: UMLS:C0359180

subject_name: albumin solution

object_name: Massive hemorrhage


subject: UMLS:C0359180

object_name: Hemorrhage


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Advanced prostate cancer


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals

object_name: acute graft versus host disease


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: CHEBI:8378

subject_name: Prednisolone

object_name: cocaine dependence


subject: CHEBI:8378

object_name: opiate dependence


subject: UMLS:C4086364

subject_name: GlyT2/5HT2A Antagonist VVZ-149

object_name: radiculopathy


subject: UMLS:C4086364

object_name: sciatica


subject: CHEBI:31593

subject_name: fasudil hydrochloride

object_name: Parkinson disease


subject: CHEBI:43871

subject_name: Fasudil


subject: UMLS:C0526099


subject: MESH:C000627796

subject_name: Nano-PSO

object_name: Menopause present (finding)


subject: MESH:C000627796

object_name: Menopause


subject: MESH:C000627796

object_name: Vasomotor disturbance


subject: MESH:C000711993

subject_name: Ocufolin

object_name: diabetic retinopathy


subject: MESH:C000711993

object_name: dry eye syndrome


subject: MESH:C000711993

object_name: multiple sclerosis


subject: MESH:C000711993

object_name: Presenile dementia


subject: MESH:C000711993

object_name: dementia


subject: MESH:C000711993

object_name: presbyopia


subject: MESH:C000711993

object_name: myopia


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: esophageal adenocarcinoma


subject: PUBCHEM.COMPOUND:71301229

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:71301229

object_name: cervical adenocarcinoma


subject: PUBCHEM.COMPOUND:71301229

object_name: adenocarcinoma


subject: PUBCHEM.COMPOUND:71301229

object_name: bile duct adenocarcinoma


subject: UMLS:C0305578

subject_name: Centrum

object_name: non-small cell lung carcinoma


subject: UMLS:C5206830

subject_name: GHR Antisense Oligonucleotide IONIS-GHR-LRx

object_name: acromegaly


subject: UMLS:C5206830

object_name: Acral overgrowth


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: blindness


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: asthma


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib

object_name: pancreatic neoplasm


subject: UNII:CEGM9YBNGD

object_name: exocrine pancreatic carcinoma


subject: UNII:CEGM9YBNGD

object_name: malignant pancreatic neoplasm


subject: PR:000001544

subject_name: programmed cell death 1 ligand 2

object_name: follicular lymphoma


subject: UMLS:C4724848

subject_name: PD-L1 Peptide Vaccine


subject: UMLS:C0370003

subject_name: Specimen


subject: PUBCHEM.COMPOUND:3222

object_name: non-Hodgkin lymphoma


subject: CHEBI:4784

subject_name: Enalapril


subject: UNII:971Z4W1S09

subject_name: Technetium Tc-99m sestamibi

object_name: triple-negative breast carcinoma


subject: UNII:971Z4W1S09

object_name: HER2/Neu Negative


subject: UNII:971Z4W1S09

object_name: Estrogen Receptor Negative


subject: UNII:971Z4W1S09

object_name: Progesterone Receptor Negative


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:7466

subject_name: Nandrolone

object_name: Growth & development aspects


subject: CHEBI:7466

object_name: cardiac arrest


subject: CHEBI:7466

object_name: Encounter due to problems related to other legal circumstances - arrest


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:2569

subject_name: Alfentanil

object_name: disorientation


subject: CHEBI:2569

object_name: Confusion


subject: CHEBI:2569

object_name: digestive system disorder


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:119915


subject: UMLS:C5421047

subject_name: Petosemtamab

object_name: colorectal cancer


subject: UMLS:C5421047

object_name: colorectal carcinoma


subject: UMLS:C5421047

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5421047

object_name: carcinoma of esophagus


subject: UMLS:C5421047

object_name: esophageal cancer


subject: UMLS:C5421047

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5421047

object_name: neoplasm of esophagus


subject: UMLS:C5421047

object_name: Stomach cancer


subject: UMLS:C5421047

object_name: gastric cancer


subject: UMLS:C5421047

object_name: Gastroesophageal junction cancer


subject: UMLS:C5421047

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:135659064


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Tourette syndrome


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: transitional cell carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:9123

subject_name: Sertraline

object_name: coccidioidomycosis


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: primary hyperparathyroidism


subject: UNII:1C6V77QF41

object_name: secondary hyperparathyroidism


subject: UNII:UZ29E6L2X8

subject_name: Acemannan

object_name: oral candidiasis


subject: MESH:C000729886

object_name: acute kidney failure


subject: UMLS:C3712707


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: CHEBI:5931

subject_name: insulin human


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:3080587

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:3080587

object_name: Good quality of life


subject: CHEBI:71954

subject_name: Buparlisib

object_name: thymoma


subject: CHEBI:71954

object_name: thymus neoplasm


subject: UMLS:C5237721

subject_name: FAK1 Inhibitor IN10018

object_name: metastatic melanoma


subject: UNII:1C6V77QF41

object_name: Insulin Sensitivity


subject: UNII:1C6V77QF41

object_name: Disorder of intraocular pressure


subject: UNII:1C6V77QF41

object_name: Intraocular Pressure


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:40133

subject_name: (R)-Rolipram

object_name: endogenous depression


subject: CHEBI:40133

object_name: major depressive disorder


subject: CHEBI:104872

subject_name: Rolipram


subject: CHEBI:104872


subject: CHEBI:4974

subject_name: Famciclovir

object_name: herpes labialis


subject: CHEBI:26333

subject_name: prostaglandin

object_name: ocular hypertension


subject: CHEBI:26333

object_name: Ocular hypertension


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: grade III meningioma


subject: UNII:MRL3739G66

object_name: Grade I Meningioma


subject: UNII:MRL3739G66

object_name: grade II meningioma


subject: UNII:MRL3739G66

object_name: Unresectable Meningioma


subject: UNII:HD4TW8S2VK

subject_name: Pridopidine

object_name: Parkinson disease


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: diabetic ketoacidosis


subject: CHEBI:8228

object_name: HYPERGLYCEMIA, SEVERE


subject: CHEBI:8228

object_name: diabetes mellitus, ketosis-prone


subject: CHEBI:8688

subject_name: Pyrvinium pamoate

object_name: Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:8688

object_name: Stage 0 Pancreatic Cancer AJCC v8


subject: CHEBI:8688

object_name: Stage I Pancreatic Cancer AJCC v8


subject: CHEBI:8688

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:8688

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:8688

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:8688

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:8688

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:94823


subject: CHEBI:94823


subject: CHEBI:94823


subject: CHEBI:94823


subject: CHEBI:94823


subject: CHEBI:94823


subject: CHEBI:94823


subject: CHEBI:94823


subject: CHEBI:8687

subject_name: Pyrvinium


subject: CHEBI:8687


subject: CHEBI:8687


subject: CHEBI:8687


subject: CHEBI:8687


subject: CHEBI:8687


subject: CHEBI:8687


subject: CHEBI:8687


subject: CHEBI:151315

subject_name: Heparin

object_name: Abdominal Neoplasms


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UMLS:C3896681

subject_name: Eltrapuldencel-T

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C3896681

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C3896681

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C3896681

object_name: metastatic melanoma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Transfusion related complication


subject: CHEBI:8228

object_name: Uncontrolled type 2 diabetes mellitus


subject: CHEBI:40237

subject_name: Sitagliptin


subject: UMLS:C0445115

subject_name: Normal saline

object_name: rheumatoid necrobiotic nodule


subject: UMLS:C0445115

object_name: rheumatoid nodulosis


subject: UMLS:C0445115

object_name: Tendinopathy


subject: UMLS:C0445115

object_name: tendinosis


subject: CHEBI:135552

subject_name: Prucalopride

object_name: paralytic ileus


subject: CHEBI:135552

object_name: Critical Illness


subject: UMLS:C0700021

subject_name: Plendil

object_name: hypertension


subject: UMLS:C0700021

object_name: Hypertension, CTCAE


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: lipodystrophy


subject: CHEBI:125400

subject_name: actinomycin D

object_name: FIGO Stage I Gestational Trophoblastic Tumor


subject: CHEBI:125400

object_name: FIGO Stage III Gestational Trophoblastic Tumor


subject: CHEBI:125400

object_name: FIGO Stage II Gestational Trophoblastic Tumor


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: bone disorder


subject: PUBCHEM.COMPOUND:4056

object_name: Chronic uremia


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: UNII:71ANL51TLA


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: CHEBI:28869


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: UNII:12V8PA4WCH


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:16374


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:44245


subject: CHEBI:31905

subject_name: Nicorandil

object_name: Presenile dementia


subject: CHEBI:31905

object_name: dementia


subject: CHEBI:31905

object_name: mild neurocognitive disorder


subject: CHEBI:31905

object_name: mild cognitive impairment


subject: CHEBI:131167

subject_name: Losmapimod

object_name: major depressive disorder


subject: UMLS:C4317273


subject: CHEBI:64816

object_name: Breast cancer stage III


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: hormone receptor-positive breast cancer


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: breast cancer


subject: PUBCHEM.COMPOUND:91820602

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:91820602

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602

object_name: Malignant neoplasm of female breast


subject: PUBCHEM.COMPOUND:91820602

object_name: invasive breast carcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: HER2 positive breast carcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602

object_name: estrogen-receptor positive breast cancer


subject: PUBCHEM.COMPOUND:91820602

object_name: breast neoplasm


subject: UMLS:C5389886

subject_name: hyaluronidase-zzxf


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: CHEBI:57858

subject_name: atropinium

object_name: mild neurocognitive disorder


subject: CHEBI:57858

object_name: mild cognitive impairment


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:92712


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C1161352


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: atypical carcinoid tumor


subject: UNII:2S9ZZM9Q9V

object_name: gastric neuroendocrine tumor G1


subject: UNII:2S9ZZM9Q9V

object_name: colorectal neuroendocrine tumor G1


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: APUdoma


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: UMLS:C0021735

subject_name: Viraferon

object_name: neuroendocrine neoplasm


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE

object_name: Bronchospasm, Exercise-Induced


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: PUBCHEM.COMPOUND:3021749


subject: UNII:J697UZ2A9J


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: pouchitis


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Carcinoma breast stage IV


subject: UNII:15C2VL427D

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:15C2VL427D

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A

object_name: nephrotoxicity


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Control of hip fracture risk


subject: CHEBI:73604

object_name: hip fracture


subject: CHEBI:73604

object_name: Intraoperative Hemorrhage


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: PUBCHEM.COMPOUND:435949


subject: PUBCHEM.COMPOUND:435949


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Pain Disorder


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:50858

subject_name: corticosteroid

object_name: osteoarthritis


subject: CHEBI:50858


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3540725


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3539185


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540726


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UMLS:C3540727


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Senile purpura


subject: CHEBI:15367

object_name: Skin tear


subject: CHEBI:15367

object_name: Dermatoporosis


subject: UMLS:C1721258

object_name: infertility


subject: GTOPDB:3711


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Chronic systolic heart failure


subject: CHEBI:26710

object_name: third-degree atrioventricular block


subject: CHEBI:26710

object_name: AV Block Third Degree by ECG Finding


subject: CHEBI:26710

object_name: sick sinus syndrome


subject: CHEBI:26710

object_name: Sick Sinus Syndrome, CTCAE


subject: CHEBI:26710

object_name: Syncope Related to COVID-19


subject: CHEBI:26710

object_name: Syncope, CTCAE 5.0


subject: CHEBI:26710

object_name: Syncope


subject: CHEBI:85990

subject_name: Panobinostat

object_name: renal carcinoma


subject: CHEBI:85990

object_name: kidney cancer


subject: UNII:D07V79Q44T


subject: UNII:D07V79Q44T


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: reported prior thyroid disease (history)


subject: CHEBI:52763

object_name: inborn mitochondrial myopathy


subject: UNII:7K5O7P6QIU

subject_name: LONCASTUXIMAB

object_name: Waldenstrom macroglobulinemia


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: vitamin C measurement


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate

object_name: estradiol measurement


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:5181

subject_name: fucoidan

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:165505

subject_name: Mercaptopropionylglycine

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:32229

subject_name: Tiopronin


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: thyroid tumor


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:70839

subject_name: Dasatinib

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:70839

object_name: EGFR gene mutation


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: sarcoidosis


subject: UNII:91X1KLU43E

object_name: sarcoidosis, susceptibility to, 1


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab


subject: UNII:FU77B4U5Z0


subject: CHEBI:35430

subject_name: DIIODOTHYRONINE

object_name: COPD, severe early onset


subject: CHEBI:35430

object_name: chronic obstructive pulmonary disease


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:29298

subject_name: ditritium


subject: CHEBI:29298


subject: PR:000003610


subject: PR:000003610


subject: UniProtKB:Q06666

subject_name: T2_MOUSE Octapeptide-repeat protein T2 (sprot)


subject: UniProtKB:Q06666


subject: PR:000034234

subject_name: octapeptide-repeat protein T2


subject: PR:000034234


subject: PR:000016619

subject_name: trafficking protein particle complex subunit 9


subject: PR:000016619


subject: PR:000008994

subject_name: interleukin-1 receptor-like 1


subject: PR:000008994


subject: PR:000003595

subject_name: 3-ketoacyl-CoA thiolase, mitochondrial


subject: PR:000003595


subject: CHEBI:135005

subject_name: Milnacipran

object_name: shoulder pain chronic


subject: CHEBI:135005

object_name: chronic shoulder pain


subject: UMLS:C5854631

subject_name: DNA Plasmid Vaccine ITI-1001

object_name: glioblastoma


subject: UMLS:C5854631

object_name: Childhood Glioblastoma


subject: UMLS:C5854631

object_name: adult glioblastoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: autosomal dominant polycystic kidney disease


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: abortion


subject: UMLS:C0592155

subject_name: Syntocinon


subject: GTOPDB:8264

subject_name: fresolimumab

object_name: Carcinoma breast stage IV


subject: UNII:375142VBIA


subject: UMLS:C1832030


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Postoperative delirium


subject: CHEBI:6456

object_name: Emergence Delirium


subject: CHEBI:135940

subject_name: olaflur

object_name: gingivitis


subject: UMLS:C5198742

object_name: Hepatic impairment


subject: CHEBI:144094

subject_name: bicalutamide

object_name: salivary gland cancer


subject: CHEBI:63633

subject_name: Triptorelin

object_name: salivary gland carcinoma


subject: CHEBI:63633


subject: UNII:A3XY0AJU50

object_name: type 2 diabetes mellitus


subject: UNII:89DNT9F435


subject: PUBCHEM.COMPOUND:71587993


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Neoplasm, Residual


subject: CHEBI:66919

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:134738

subject_name: Laquinimod

object_name: primary progressive multiple sclerosis


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: PUBCHEM.COMPOUND:92043599


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: PUBCHEM.COMPOUND:152165

object_name: Ectopic ossification


subject: PUBCHEM.COMPOUND:152165

object_name: Hip arthropathy


subject: PUBCHEM.COMPOUND:152165

object_name: Myositis ossificans traumatica, thigh


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: UNII:2M2GGL7HUP

subject_name: FOLLITROPIN DELTA

object_name: female infertility


subject: UMLS:C4301617

subject_name: follitropin delta


subject: UNII:JQ95208805

subject_name: Apomine

object_name: osteoporosis


subject: UNII:JQ95208805

object_name: Encounter due to family history of osteoporosis


subject: UNII:JQ95208805

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:JQ95208805

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C5201249

subject_name: CXCR4 INHIBITOR X4P-001

object_name: WHIM syndrome 1


subject: UMLS:C5201249

object_name: WHIM syndrome


subject: CHEBI:63115

subject_name: Fingolimod

object_name: brain edema


subject: CHEBI:63115

object_name: Intraparenchymal hemorrhage of brain


subject: CHEBI:63115

object_name: Cerebral Hemorrhage, Hypertensive